Primary Cells Market Size is valued at USD 1.94 Bn in 2024 and is predicted to reach USD 5.18 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034.
Primary cells are cells isolated from a living organism as opposed to "cell lines," which have been grown for a long time and are frequently employed in various biological and medical research purposes. Because they more closely resemble cells in living organisms and provide a more precise depiction of cell behaviour, operation, and responses to stimuli than immortalized cell lines, human primary cells are in high demand by research institutes and pharmaceutical companies for developing potential cancer medicines and treatments.
In addition, Growth in the pharmaceutical and biotechnology sectors, rising demand for monoclonal antibodies, increasing government investments in cell-based research, and growing interest in cancer treatment are all factors driving the expansion of this market. More in-depth studies using primary cells by researchers and drug development companies have become possible thanks to developments in automation, single-cell analysis, and imaging technologies, and these developments, along with infrastructure improvements, are expected to stoke the market's Growth over the next few years.
However, the market expansion may be hampered by the scarcity of particular cell types and fresh samples due to cell source restrictions and a short lifespan in culture. In addition, the primary cell market benefited from COVID-19. Researchers study the infection and develop standardized epithelial cell culture models using primary cell culture. These models can help replicate the characteristics of the respiratory system, which could lead to important medical discoveries.
Furthermore, there has been a rise in the isolation of primary cells for treating various illnesses. Private organizations, biotech firms, and government bodies have all increased their focus and funding on these technologies as they find more and more uses in healthcare. Primary cell cultures are becoming increasingly popular for viral synthesis, which is utilized to produce a wide variety of vaccines.
The primary cells market is segmented based on type, origin and end-user. Based on type, the market is segmented into hematopoietic, dermatocytes, hepatocytes, gastrointestinal, lung, renal, heart, and musculoskeletal. By origin, the market is segmented into human primary cells and animal primary cells. By end user, the market is segmented into life science research companies, research institutes, and others.
The hematopoietic primary cells category is expected to hold a major global market share due to the rising prevalence of blood malignancies and other immune system illnesses, as well as factors such as the use of Hematopoietic cell transplants and the research and development of novel cancer medicines. The largest projected growth rate is anticipated for hepatocytes because of their rising demand in toxicological and pharmacological research.
The human primary cells segment is projected to grow rapidly in the global Primary Cells market. Human primary cells have been used extensively in cancer cell research and toxicity. Demand for reliable disease models, progress in research and drug discovery, the emergence of regenerative medicine, the need for rigorous safety testing, the growing prevalence of chronic diseases, technological advances, ethical considerations, and scientific collaborations are all factors propelling the human market forward, especially in countries like the US, Germany, the UK, China, and India.
The North America primary cells market activity is anticipated to record the largest market share in revenue in the near future. It can be attributed to because of the high price of healthcare, the growing number of elderly, the increasing incidence of chronic diseases, and the money provided by the government.
Furthermore, growing interest in gene therapy, the availability of new research tools, and the expansion of the field all contribute to the size of the market in the United States. In addition, Asia Pacific is projected to grow rapidly in the global primary cells market due to the industry's focus on developing innovative applications for cultivating cells, improving its instruments, expanding its repertoire of cell kinds, and studying the intercellular interactions between them.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.94 Bn |
|
Revenue Forecast In 2034 |
USD 5.18 Bn |
|
Growth Rate CAGR |
CAGR of 10.4 % from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Origin, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Inc., Merck Kgaa, Corning Incorporated, Lonza Group, Charles River Laboratories, Inc., Promocell Gmbh, American Type Culture Collection (ATCC), Cell Biologics, Inc., Zenbio, Inc., Stemcell Technologies, Inc., Allcells, Ixcells Biotechnologies, Neuromics, Axol Bioscience Ltd., Stemexpress, Bioivt, Sciencell Research Laboratories, Inc., Amsbio, Promab Biotechnologies, Inc., Creative Bioarray, Bps Bioscience, Inc., Epithelix, Reachbio Research Labs, Accegen, Kosheeka and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Primary Cells Market Snapshot
Chapter 4. Global Primary Cells Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Hematopoietic,
5.2.2. Dermatocytes,
5.2.3. Hepatocytes,
5.2.4. Gastrointestinal,
5.2.5. Lung,
5.2.6. Renal,
5.2.7. Heart,
5.2.8. Musculoskeletal
Chapter 6. Market Segmentation 2: By Origin Estimates & Trend Analysis
6.1. By Origin & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Origin:
6.2.1. Human Primary Cells,
6.2.2. Animal Primary Cells
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
7.2.1. Life Science Research Companies,
7.2.2. Research Institutes,
7.2.3. Others
Chapter 8. Primary Cells Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
8.1.2. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Origin, 2019-2031
8.1.3. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
8.1.4. North America Primary Cells Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Primary Cells Market revenue (US$ Million) By Type, 2019-2031
8.2.2. Europe Primary Cells Market revenue (US$ Million) By Origin, 2019-2031
8.2.3. Europe Primary Cells Market revenue (US$ Million) By End User, 2019-2031
8.2.4. Europe Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Primary Cells Market revenue (US$ Million) By Type, 2019-2031
8.3.2. Asia Pacific Primary Cells Market revenue (US$ Million) By Origin, 2019-2031
8.3.3. Asia Pacific Primary Cells Market revenue (US$ Million) By End User, 2019-2031
8.3.4. Asia Pacific Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.4.2. Latin America Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031
8.4.3. Latin America Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.4.4. Latin America Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Primary Cells Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.2. Merck KgAa
9.2.3. Corning Incorporated
9.2.4. Lonza Group
9.2.5. Charles River Laboratories, Inc.
9.2.6. PromoCell Gmbh
9.2.7. American Type Culture Collection (ATCC)
9.2.8. Cell Biologics, Inc.
9.2.9. Zen-Bio, Inc.
9.2.10. Stemcell Technologies, Inc.
9.2.11. AllCells
9.2.12. iXCells Biotechnologies
9.2.13. Neuromics
9.2.14. Axol Bioscience Ltd.
9.2.15. StemExpress
9.2.16. Bioivt
9.2.17. ScienCell Research Laboratories, Inc.
9.2.18. AMSBIO
9.2.19. ProMab Biotechnologies, Inc.
9.2.20. Creative Bioarray
9.2.21. Bps Bioscience, Inc.
9.2.22. Epithelix
9.2.23. Reachbio Research Labs
9.2.24. AcceGen
9.2.25. Kosheeka
9.2.26. Others
Primary Cells Market By Type -
Primary Cells Market By Origin -
Primary Cells Market By End User -
Primary Cells Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
